MX9201665A - Composicion farmaceutica para el tratamiento de infecciones del virus de inmunodeficiencia humana del tipo 1 en mamiferos. - Google Patents

Composicion farmaceutica para el tratamiento de infecciones del virus de inmunodeficiencia humana del tipo 1 en mamiferos.

Info

Publication number
MX9201665A
MX9201665A MX9201665A MX9201665A MX9201665A MX 9201665 A MX9201665 A MX 9201665A MX 9201665 A MX9201665 A MX 9201665A MX 9201665 A MX9201665 A MX 9201665A MX 9201665 A MX9201665 A MX 9201665A
Authority
MX
Mexico
Prior art keywords
mammals
treatment
type
pharmaceutical composition
immunodeficiency virus
Prior art date
Application number
MX9201665A
Other languages
English (en)
Inventor
Richard Anthony Vere Hodge
Martin David John Kenig
Original Assignee
Smithkline Beecham P I C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P I C filed Critical Smithkline Beecham P I C
Publication of MX9201665A publication Critical patent/MX9201665A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9201665A 1991-04-13 1992-04-10 Composicion farmaceutica para el tratamiento de infecciones del virus de inmunodeficiencia humana del tipo 1 en mamiferos. MX9201665A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919107896A GB9107896D0 (en) 1991-04-13 1991-04-13 Pharmaceuticals

Publications (1)

Publication Number Publication Date
MX9201665A true MX9201665A (es) 1992-10-01

Family

ID=10693221

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9201665A MX9201665A (es) 1991-04-13 1992-04-10 Composicion farmaceutica para el tratamiento de infecciones del virus de inmunodeficiencia humana del tipo 1 en mamiferos.

Country Status (10)

Country Link
EP (1) EP0580657A1 (es)
JP (1) JPH06506673A (es)
AU (1) AU1541292A (es)
CA (1) CA2108175A1 (es)
GB (1) GB9107896D0 (es)
IE (1) IE921156A1 (es)
MX (1) MX9201665A (es)
PT (1) PT100367A (es)
WO (1) WO1992018130A1 (es)
ZA (1) ZA922702B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648211A (en) * 1994-04-18 1997-07-15 Becton, Dickinson And Company Strand displacement amplification using thermophilic enzymes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY101126A (en) * 1985-12-13 1991-07-31 Beecham Group Plc Novel compounds
GB8713695D0 (en) * 1987-06-11 1987-07-15 Beecham Group Plc Process
EP0353955A3 (en) * 1988-08-02 1991-08-14 Beecham Group Plc Novel compounds
GB8918827D0 (en) * 1989-08-17 1989-09-27 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
GB9107896D0 (en) 1991-05-29
EP0580657A1 (en) 1994-02-02
AU1541292A (en) 1992-11-17
PT100367A (pt) 1993-07-30
CA2108175A1 (en) 1992-10-14
JPH06506673A (ja) 1994-07-28
IE921156A1 (en) 1992-10-21
ZA922702B (en) 1992-12-30
WO1992018130A1 (en) 1992-10-29

Similar Documents

Publication Publication Date Title
RU93045710A (ru) Противовирусная нуклеозидная композиция, способ ее получения и способ лечения
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
DK0574457T3 (da) Antiviral nucleosidkombination
IE862554L (en) Pharmaceutical compositions
MX9202436A (es) Composiciones para el cuidado del cabello y metodo para su preparacion.
MX9201245A (es) Nueva formulacion de vacuna para tratar infecciones cuasadas por el virus de herpes simple.
BR9907995A (pt) Métodos imunológicos para modular miostatina em sujeitos vertebrados
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
DE69419377D1 (de) Neurotensin-aktive substituierte 1-Naphthylpyrazol-3-carboxamide, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
ES2141116T3 (es) Utilizacion del peptido natriuretico atrial humano para la obtencion de un medicamento para el tratamiento del sindrome de dificultad respiratoria en el adulto.
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
MX9200948A (es) Composicion farmaceutica para el tratamiento de isquemia cerebral en mamiferos.
ATE71840T1 (de) Virushemmende nukleosidmischung.
MX9301935A (es) Compuestos para el tratamiento de alteraciones neurodegenerativas.
MX9202507A (es) Composicion farmaceutica para el tratamiento de esofagitis de reflujo.
MX9201665A (es) Composicion farmaceutica para el tratamiento de infecciones del virus de inmunodeficiencia humana del tipo 1 en mamiferos.
MX9102512A (es) Administracion oral de interferon alfa en el tratamiento de enfermedades del pulmon.
MX9201258A (es) Compuestos para el tratamiento del cancer y procedimiento para su preparacion.
MX9302578A (es) Agentes antivirales.
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
ES2019583B3 (es) Composicion para el tratamiento de infecciones.
IT9048244A0 (it) Composizione farmaceutica ad effetto cicatrizzante.
MX9200555A (es) Composicion farmaceutica para la aplicacion topicaterapeutica en el tratamiento de catarata pre-senil y senil.
MX9204485A (es) Composicion farmaceutica para el tratamiento de enfermedades inflamatorias.